To,



Title of the article:

[Type or copy/paste your title here]

Because of the double-blind review, the authors’ information should not be included in this file. Please put authors’ information in the separated Title Page.

Abstract:

[The abstract succinctly introduces the paper. It is advised not to exceed 250–300 words. Please do not include any citations in the abstract. Avoid specialist abbreviations if possible.]

Key Words：

[Four to six keywords for indexing purpose]

1. Introduction

[Type or copy/paste your text here]

2. Case Presentation

[Type or copy/paste your text here]

Number tables consecutively in accordance with their appearance in the text. Place a table’s caption above the table’s body and its description below the body. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.

For example:

Table 1. This is the title of the table

|Groups |Item A | |Item B |

| |N |M | |n |M |

|Control Group |1.584* |0.487 | |1.682** |0.0627 |

|* This the first footnote. |

|**This is another footnote. |

As shown in Table 1, the experimental group, and control group …

Number figures consecutively in accordance with their appearance in the text. Place a figure’s caption and description below the figure body. A minimum resolution of 300 DPI is required.

For each figure, the following information should be provided: Figure number (in sequence, using Arabic numerals - i.e. Figure 1, 2, 3 etc); short title of figure (maximum 15 words); detailed legend, up to 300 words.

[pic]

Figure 1. Figure title (This is an example of figure 1)

As shown in Figure 1, the experimental group, and control group …

Note: Avoid abbreviating the titles of tables, figures, and equations (i.e., Tab. 1, Fig. 2, Eq. 3) in the caption or in running text. Do not write “the table above/below” or “the figure on page 32,” because the position and page number of a table or figure cannot be determined until the pages are typeset.

[Subheading level 2]

[Type or copy/paste your text here]

[Subheading level 3]

[Type or copy/paste your text here]

3. Discussion

[Type or copy/paste your text here]

Acknowledgement

Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship.

References

All references must be numbered consecutively, in square brackets, in the order in which they are cited in the text (such as [1]), followed by any in tables or legends. Reference citations should not appear in titles or headings. Each reference must have an individual reference number. Please avoid excessive referencing. If automatic numbering systems are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission.

Reference style should refer to NLM citation style, see Citing Medicine: the NLM style guide for authors, editors, and publishers ()

Examples of reference style are shown below:

1] Verdecchia A, Francisci S, Brenner H. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 2007;8:784-796. (07)70246-2

2] Baselga J, Segalla JGM, Roché H. 3LBA SOLTI-0701: a double-blind, randomized phase 2b study evaluating the efficacy and safety of sorafenib (SOR) compared to placebo (PL) when administered in combination with capecitabine (CAP) in patients (pts) with locally advanced (adv) or metastatic (met) breast cancer (BC). Eur J Cancer Suppl 2009;7:3. (09)72031-2

3] Carey LA, Dees EC, Sawyer L. The triple negative paradox: primary minimizing chemosensitivity of breast cancer subtypes. Clin Cancer Res,in press.

4] Jones S, Holmes FA, O'Shaughnessy J. Docetaxel with cyclophosphamide is associated with an overall survival benefit compared with doxorubicin and cyclophosphamide: 7-year follow-up of US Oncology Research Trial 9735[abstract]. J Clin Oncol 2009;27:s1177-s1183. PMid:19204201

5] Jones X. Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann, 1996:16-27.

Copyrights

Copyright for this article is retained by the author(s), with first publication rights granted to the journal.

This is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license ().

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download